Jim Cramer on pharma stocks amid proposed Covid vaccine patent waiver

The Biden administration said Wednesday it supports waiving intellectual property protections for Covid vaccines, as other countries around the world struggle to manufacture the life-saving doses. Pfizer CEO Albert Bourla on CNBC on Tuesday that such a move would not impact the production of its Covid vaccine. CNBC's Jim Cramer weighs in on how this could affect pharma stock valuations.